CD4+ T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 468-473

  Kudeken, N ^a   Kawakami, K ^a   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

CD4+ T cells; Hyperinflammatory reaction; Penicilliosis marneffei

Indexed keywords

CD4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; FLOW CYTOMETRY; MALE; MOUSE; MYCOSIS; NONHUMAN; PENICILLIUM MARNEFFEI; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031057999     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.00293.x     Document Type: Article

References (45)

1. McGinnis MR. Penicillium marneffei, dimorphic fungus of increasing importnce. Clin Microbiol Newslett 1994; 16:29-31.
2. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344:110-3.
3. Jayanetra P, Nitiyanant P, Ajello L et al. Penicilliosis marneffei in Thailand: report of five human cases. Am J Trop Med Hyg 1984; 33: 637-44.
4. So SY, Chau PY, Jones BM, Wu PC, Pun KK, Lam WK, Lawton JWM. A case of invasive penicilliosis in Hong Kong with immunologic evaluation. Am Rev Respir Dis 1985; 131:662-5.
5. Hilmarsdottir I, Meynard JL, Rogeaux O et al. Disseminated Penicillium marneffei infection associated with human immunodeficiency viruses: a report of two cases and review of 35 published cases. J Acquired Immune Defic Syndr 1993; 6:466-71.
6. Sirisanthana V, Sirisanthana T. Penicillium marneffei infection in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1993; 12:1021-5.
7. Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1992 14:871-4.
8. Tsang DNC, KLi PC, Tsui MS, Lau YT, Ma KF, Yeoh EK. Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus. Rev Infect Dis 1991; 13:766-7.
9. Dupont B, Denning DM, Marriott D, Sugar AM, Viviani MA, Sirisanthna T. Mycoses in AIDS patients. J Med Vet Mycol 1994; 32 (Suppl. 1):65-77.
10. Supparatpinyo K, Nelson KE, Merz WG, Breslin BJ, Cooper C Jr, Kamwan C, Sirisanthana T. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother 1993; 37:2407-11.
11. Deng ZL, Yun M, Ajello L. Human penicillosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus). J Med Vet Mycol 1986; 24:383-9.
12. Chariyalertsak S, Vanittanakom P, Nelson KE, Sirisanthana T, Vanittanakom N. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol 1996; 34:105-10.
13. Kudeken N, Kawakami K, Kusano N, Saito A. Contribution of cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J Med Vet Mycol 1996; 34:in press.
14. + T cells into severe combined immunodeficiency mice. J Clin Invest 1992; 90:673-8.
15. Roths JB, Sidman CL. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect Immun 1993; 61:1641-9.
16. Kawakami K, Kohno S, Morikawa N, Kadota J, Saito A, Hara K. Activation of macrophages and expansion of specific T cells in the lungs of mice intratracheally inoculated with Cryptococcus neoformans. Clin Exp Immunol 1994; 96:230-7.
17. Abrams JS, Roncarolo MG, Yssel H, Anderson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5-24.
18. Morisaki T, Goya T, Toh H, Nishihara K, Torisu M. The anti Mac-1 monoclonal antibody inhibits neutrophil sequestration in lung and liver in a septic murine model. Clin Immunol Immunopathol 1991; 61:365-75.
19. Adams DO. Molecular interactions in macrophage activation. Immunol Today 1989; 10:33-35.
20. Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-9.
21. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Moldawer LL. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146:3478-82.
22. Berry LJ. Bacterial toxins. Crit Rev Toxicol 1987; 5:239-51.
23. Morrison DC, Ryan JL. Endotoxin and disease. Annu Rev Med 1987; 38:417-32.
24. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53:488-98.
25. Yoshimoto T, Nakanishi K, Hirose S et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 1992; 148:3596-603.
26. Smith SR, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J Leukoc Biol 1993; 54:23-29.
27. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53:488-98.
28. Hesse DG, Tracey KJ, Fong Y, Manougue KR, Palladino MA, Cerami A, Shires GT, Lowry SF. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1987; 166:147-53.
29. Leal JA, Guerrero C, Gomez-Miranda B, Prieto A, Bernabe M. Chemical and structural similarities in wall polysaccharides of some Penicillium, Eupenicillium and Aspergillus species. Fems Microbiol Lett 1992; 69:165-8.
30. Sakurai T, Ohno N, Suzuki I, Yadomae T. Effect of soluble fungal (1→3)-β-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation. Immunopharmacol 1995; 30:157-66.
31. Abel G, Czop JK. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int J Immunopharmacol 1992; 14:1363-73.
32. Nacy CA, Meltzer MS. T cell-mediated activation of macrophages. Curr Opin Immunol 1991; 3:330-5.
33. Bauss F, Droge W, Mannel DN. Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun 1987; 55:1622-5.
34. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-71.
35. Tracey KJ, Fong Y, Hesse DG, Manpgue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-4.
36. Nacy CA, Meierovics AI, Belosevic M, Green SJ. Tumor necrosis factor-α: central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathology 1991; 59:182-7.
37. Harvell EA. Production of tumor necrosis factor during murine listeriosis. J Immunol 1987; 139:4225-31.
38. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant tumor necrosis factor-α in murine salmonelosis. J Immunol 1990; 144:1935-41.
39. Blanchard DK, Djeu JY, Klein TW, Friedman H, Stewart WE II. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukocyte Biol 1988; 43:429-35.
40. Denis M. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J Leukocyte Biol 1991; 50:495-501.
41. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62:3-6.
42. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1993; 55:97-179.
43. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated antigen 1 (LFA-1). Cell 1987; 51:813-9.
44. Lollo BA, Chan KW, Hanson EM, Moy VT, Brian AA. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J Biol Chem 1993; 268:21693-700.
45. Miller RF, Semple SJ. Glucocorticoid therapy for severe Pneumocystis carinii pneumonia. J Infect 1990; 21:131-7.